Twenty-nine patients with ON (20 unilateral and 9 bilateral) were recruited prospectively from the neuro-ophthalmology clinic at the University of Iowa Department of Ophthalmology and Visual Sciences. After exclusion of eyes with concurrent retinal abnormalities, the two study groups consisted of 35 eyes with ON and 19 unaffected eyes. Mean subject age was 51 years, and the etiology and duration of ON varied among patients, including nonarteritic ischemic ON (NAION; n = 7; duration [years]: 0.08, 0.3, 0.6, 0.83, 1.8, 3.1, 12.6), arteritic ION (n = 3; duration [years]: 1.3, 2.2, 5.0), nonarteritic posterior ION (n = 2; duration [years]: 1.3, 3.1), compressive ON (n = 7; duration [years]: 0.6, 1.8, 2.6, 2.8, 2.8, 6.6, 22), demyelinating optic neuritis (n = 6; duration [years]: 0.08, 0.08, 0.1, 1.0, 6.0, 6.9), Leber hereditary ON (n = 2; duration [years]: 0.3, 3.6), optic disc drusen (n = 1; duration [years]: 0.12), and optic nerve hypoplasia (n = 1; congenital). Of the six patients with optic neuritis, three (two with central scotomata) were evaluated within 6 weeks of developing vision loss, and three (two with persistent central scotomata) were evaluated after more than 1 year. Snellen visual acuity and perimetry were performed on all patients. Visual fields were assessed using either Goldmann kinetic perimetry (26 patients) or automated perimetry (3 patients) with a Humphrey Field Analyzer II (Carl Zeiss Meditec, Inc., Jena, Germany) and the 24-2 Swedish Interactive Thresholding Algorithm (SITA) standard protocol.
The research adhered to the tenets of the Declaration of Helsinki, and the research was approved by the institutional review board at the University of Iowa. Written, informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study.